A5229A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDI

A5229A URIDI 的 II/III 期、随机、双盲、安慰剂对照试验

• 批准号: 7606094
• 负责人: Henry H. BALFOUR
• 金额: $ 0.11万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7606094
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Fatty acid glycerol esters; Funding; Grant; Institution; Limb structure; Measures; Phase; Placebos; Randomized; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Upper arm; Uridine; Week; double-blind placebo controlled trial

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective is to look at the effect of uridine on limb fat by comparing changes from baseline to week 48 in DEXA-measured limb fat between the uridine arm and the placebo arm.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 主要目的是通过比较尿苷组和安慰剂组之间从基线到第48周的DEX测量肢体脂肪的变化来观察尿苷对肢体脂肪的影响。